SCHEMBL22345497

SCHEMBL22345497

COP(=O)(O)c1cnnc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.36
▸ LMNA P02545 3/20 0.36
▸ ALOX15 P16050 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ GPR3 P46089 1/20 0.35
▸ POLB P06746 2/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ TGFBR1 P36897 1/20 0.32
▸ HCRTR1 O43613 1/20 0.32
▸ HCRTR2 O43614 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22345382 0.85 GPR3 (0.39) ALDH1A1LMNAALOX15KDM4ECYP3A4
SCHEMBL10742424 0.82 GPR3 (0.41) ALDH1A1LMNAGPR3POLBTGFBR1
SCHEMBL22345426 0.74 CYP1A2 (0.38) ALDH1A1GPR3CYP1A2TGFBR1HCRTR1
SCHEMBL22345431 0.74 MEN1 (0.42) ALDH1A1LMNAKDM4EMAPTHPGD
SCHEMBL22345518 0.72 MEN1 (0.36) ALDH1A1LMNAKDM4EMAPTHPGD
SCHEMBL22345395 0.69 NR1I2 (0.38) ALDH1A1LMNAKDM4EHPGDPOLB
SCHEMBL18261817 0.68 CA12 (0.45) ALDH1A1LMNAKDM4EHPGDMAPK1
SCHEMBL640308 0.68 KDM4E (0.55) ALDH1A1LMNAKDM4EMAPTHPGD
SCHEMBL24400252 0.68 HDAC3 (0.49) ALDH1A1LMNAKDM4EMAPTCYP1A2
SCHEMBL7050729 0.67 LMNA (0.47) ALDH1A1LMNAALOX15KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2022-05-05 — — US disclosed
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2022-05-05 — — US disclosed
EP-3924344-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH Syngenta Crop Protection AG (CH) 2021-12-22 — — EP disclosed
WO-2020164970-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2020-08-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH NOTUM, DDT, CYP51A1 ALDH1A1 244/4885LMNA 3064/4885ALOX15 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback